Niagen Bioscience launches drug candidate for rare genetic disease
Go back to Niagen Bioscience launches drug candidate for rare genetic disease| (NASDAQ: NAGE) | Delayed: 2.99 -0.06 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $ | |||
| Open | $3.04 | 52 Week Low | $ | |||
| Day High | $3.07 | P/E | N/A | |||
| Day Low | $2.98 | EPS | $ | |||
| Volume | 20,331 | |||||

